| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mohsen Yoosefzadeh Najafabadi, Davoud Torkamane. Machine learning-enhanced multi-trait genomic prediction for optimizing cannabinoid profiles in cannabis. The Plant journal : for cell and molecular biology. 2024-11-27. PMID:39602132. |
these results demonstrate the efficacy of integrating gs and ml in developing cannabis varieties with tailored cannabinoid profiles. |
2024-11-27 |
2024-11-29 |
Not clear |
| Biswajeet Acharya, Prafulla Kumar Sahu, Amulyaratna Behera, Jack Feehan, Durga Prasad Mishra, Vasso Apostolopoulo. Cannabinoids and the male reproductive system: Implications of endocannabinoid signaling pathways. Maturitas. vol 192. 2024-11-27. PMID:39602858. |
historically viewed as a harmful psychoactive substance, contemporary research has shown the intricate pharmacology of cannabis, with its diverse array of cannabinoids and their interactions with the endocannabinoid system. |
2024-11-27 |
2024-11-30 |
Not clear |
| Biswajeet Acharya, Prafulla Kumar Sahu, Amulyaratna Behera, Jack Feehan, Durga Prasad Mishra, Vasso Apostolopoulo. Cannabinoids and the male reproductive system: Implications of endocannabinoid signaling pathways. Maturitas. vol 192. 2024-11-27. PMID:39602858. |
understanding endocannabinoid signaling in the male reproductive system is essential to fully comprehend both the therapeutic benefits and potential drawbacks of cannabis use. |
2024-11-27 |
2024-11-30 |
Not clear |
| Anna Portugalov, Gaia Peled, Sharon Zorin, Irit Akira. Cannabidiol Modulates Neuroinflammatory Markers in a PTSD Model Conducted on Female Rats. Biomolecules. vol 14. issue 11. 2024-11-27. PMID:39595561. |
cannabidiol (cbd), a non-psychoactive cannabinoid, has shown promise as a potential treatment for ptsd. |
2024-11-27 |
2024-11-29 |
rat |
| Mariana Luz-Veiga, Adélia Mendes, Diana Tavares-Valente, Manuela Amorim, António Conde, Manuela Estevez Pintado, Helena R Moreira, João Azevedo-Silva, João Fernande. Exploring Cannabidiol (CBD) and Cannabigerol (CBG) Safety Profile and Skincare Potential. International journal of molecular sciences. vol 25. issue 22. 2024-11-27. PMID:39596290. |
in this work, we studied the safety profile for topical applications of two cannabinoids: cannabidiol (cbd) and cannabigerol (cbg) and assessed their potential as skin care ingredients. |
2024-11-27 |
2024-11-29 |
Not clear |
| Shijia Li, Weini Li, Naseeb Kaur Malhi, Junwei Huang, Quanqi Li, Ziwei Zhou, Ruiheng Wang, Jiangling Peng, Tong Yin, Honggen Wan. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules (Basel, Switzerland). vol 29. issue 22. 2024-11-27. PMID:39598860. |
cannabigerol (cbg), a non-psychoactive cannabinoid found in cannabis, has emerged as a promising therapeutic agent with a diverse range of potential applications. |
2024-11-27 |
2024-11-29 |
human |
| Garima Shukla, Rishabh Sablok, Zaitoon Shivji, Stuart Fogel, Gavin P Winston, Lysa Boissé Lomax, Ana Johnson, Helen Drive. Cannabis use, sleep and mood disturbances among persons with epilepsy - A clinical and polysomnography study from a Canadian tertiary care epilepsy center. Epilepsy research. vol 209. 2024-11-25. PMID:39586190. |
interest in anti-seizure properties of cannabinoids is increasing, with the rise in prevalence of recreational and medical cannabis use, especially across canada. |
2024-11-25 |
2024-11-28 |
Not clear |
| Amy L Patton, Luette Muir, Joshua Z Seither, Jeffrey P Walterscheid, Erin L Karschne. LC-MS/MS confirmation of 11-nor-9-carboxy-tetrahydrocannabinol (Δ8, Δ9, Δ1°) and hexahydrocannabinol (HHC) metabolites in authentic urine specimens. Journal of analytical toxicology. 2024-11-25. PMID:39586679. |
recently, tetrahydrocannabinol (thc) isomers and other semi-synthetic cannabinoids have been introduced into the consumer market as alternatives to botanical cannabis. |
2024-11-25 |
2024-11-28 |
Not clear |
| Pankaj Singh Cham, Ajeet Singh, Ashiya Jamwal, Rattandeep Singh, Radhika Anand, Diksha Manhas, Sucheta Sharma, Varun Pratap Singh, Utpal Nandi, Shashank K Singh, Parvinder Pal Sing. Discovery of Ring-Annulated Analogues of Cannabidiol as Potential Anticancer Agents: Synthesis and Biological Evaluation. ACS medicinal chemistry letters. vol 15. issue 11. 2024-11-21. PMID:39563806. |
cannabidiol (cbd) is a nonpsychoactive cannabinoid derived from |
2024-11-21 |
2024-11-23 |
Not clear |
| Samuel Cholette-Tétrault, Roland Gra. Proper counseling for diagnosis and management of cannabinoid hyperemesis syndrome: a case report. Family practice. 2024-11-20. PMID:39566098. |
cannabinoid hyperemesis syndrome (chs) is an increasingly recognized condition linked to chronic cannabis use, yet it remains frequently overlooked in clinical practice. |
2024-11-20 |
2024-11-23 |
Not clear |
| Michael R Corbett, Sabra R Jones, Ruth E Winecker, Tate Yeatma. NSC-ADID Position Statement on Performance Impairment in Safety-Sensitive Positions Related to Cannabis and Other Cannabinoids. Journal of analytical toxicology. 2024-11-19. PMID:39562327. |
nsc-adid position statement on performance impairment in safety-sensitive positions related to cannabis and other cannabinoids. |
2024-11-19 |
2024-11-23 |
Not clear |
| Jennifer M Loewen, Meara L Munn-Patterson, Katelyn E McEwen, Stephanie Vuong, Jane Alcorn, Alan L Chicoin. Analysis of cannabinoids in plasma from 38 cases of suspected cannabinoid intoxication in dogs. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). 2024-11-18. PMID:39556185. |
to quantify and characterize plasma cannabinoid concentrations in cases of suspected cannabis toxicity in dogs, identify potential correlations between clinical signs and plasma concentrations, and assess the specificity of cannabis toxicity diagnosis based on clinical signs alone. |
2024-11-18 |
2024-11-22 |
Not clear |
| Antonio Matt Reck, David P Siderovski, Steven G Kinse. The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB Neuropharmacology. 2024-11-17. PMID:39551242. |
to determine the utility of cannabinoids in treating pruritus without undesirable adverse effects, the current preclinical study investigated a range of doses of the synthetic cannabinoid agonist, win 55,212-2, and two minor cannabis phytoconstituents, Δ |
2024-11-17 |
2024-11-22 |
Not clear |
| Viktoriia Cherkasova, Olga Kovalchuk, Igor Kovalchu. Targeting carbohydrate metabolism in colorectal cancer - synergy between DNA-damaging agents, cannabinoids, and intermittent serum starvation. Oncoscience. vol 11. 2024-11-14. PMID:39534512. |
in this respect, the combination of chemotherapy with cannabinoids, especially non-psychoactive, such as cannabidiol, cannabinol and other minor cannabinoids, as well as terpenes, may become very useful. |
2024-11-14 |
2024-11-17 |
Not clear |
| Lee J Conneely, Bhavna Hurgobin, Sophia Ng, Muluneh Tamiru-Oli, Mathew G Lewse. Characterization of the Cannabis sativa glandular trichome epigenome. BMC plant biology. vol 24. issue 1. 2024-11-14. PMID:39538149. |
the glandular trichomes of cannabis sativa are an emerging model system that produce large quantities of cannabinoid and terpenoid specialised metabolites with known medicinal and commercial value. |
2024-11-14 |
2024-11-17 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Key insights into cannabis-cancer pathobiology and genotoxicity. Addiction biology. vol 29. issue 11. 2024-11-14. PMID:39538372. |
indeed this multigenerational dimension of cannabinoid genotoxicity reframes the discussion of cannabis legalization within the absolute imperative to protect the genomic and epigenomic integrity of multiple generations to come. |
2024-11-14 |
2024-11-17 |
Not clear |
| Mahsa Mohammadi, Seyed Erfan Omidiani, Ronak Azizbeigi, Abbas Haghparas. Cannabidiol Plays a Modulatory Function on the Methamphetamine-Induced Reward Through Hippocampal D2-Like Dopamine Receptors. Neurochemical research. vol 50. issue 1. 2024-11-14. PMID:39540967. |
additionally, cannabidiol (cbd), one of the primary cannabinoid components of the cannabis plant, significantly affects dopaminergic transmission and may aid in reward- and addiction-related behaviors. |
2024-11-14 |
2024-11-17 |
rat |
| Guido Cammà, Monika P Verdouw, Pim B van der Meer, Lucianne Groenink, Albert Batall. Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 91. 2024-11-14. PMID:39541799. |
while the major cannabinoids cannabidiol (cbd) and Δ9-tetrahydrocannabinol (Δ9-thc) have been more extensively researched, approximately 120 minor cannabinoids from the cannabis plant have been identified. |
2024-11-14 |
2024-11-17 |
Not clear |
| Nicholas E Robertson, Jack Connolly, Nikolay Shevchenko, Mark Mascal, Kent E Pinkerton, Sascha C T Nicklisch, Tran B Nguye. Chemical Composition of Aerosols from the E-Cigarette Vaping of Natural and Synthetic Cannabinoids. Chemical research in toxicology. 2024-11-13. PMID:39535063. |
the following cannabinoids were studied: cannabidiol (cbd), 8,9-dihydrocannabidiol (h2cbd), 1,2,8,9-tetrahydrocannabidiol (h4cbd), cannabigerol (cbg), and cannabidiolic acid (cbda). |
2024-11-13 |
2024-11-17 |
human |
| Ka Lai Yip, Michael Udoh, Laura A Sharman, Thomas Harman, Miguel Bedoya-Pérez, Lyndsey L Anderson, Samuel D Banister, Jonathon C Arnol. Cannabinoid-like compounds found in non-cannabis plants exhibit antiseizure activity in genetic mouse models of drug-resistant epilepsy. Epilepsia. 2024-11-12. PMID:39530840. |
the cannabinoid cannabidiol has established antiseizure effects in drug-resistant epilepsies such as dravet syndrome and lennox-gastaut syndrome. |
2024-11-12 |
2024-11-17 |
mouse |